RecruitingNot Applicable

Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

United States342 participantsStarted 2023-12-08

Plain-language summary

Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking (EMR-MM) and endoscopic mucosal resection with thermal margin ablation (EMR-STSC)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18 years or older
✓. Ability to provide informed consent
✓. Patient scheduled to undergo colonoscopy for the evaluation and removal of colon polyps
✓. Non-pedunculated polyps ≥ 20 mm size

Exclusion criteria

✕. Pedunculated polyps
✕. Inflammatory bowel disease
✕. Inability to provide informed consent
✕. Lesions \< 20 mm in size (largest dimension)
✕. Lesion involves the lips of the ileocecal valve, is located at the appendiceal orifice and/or is fully circumferential.
✕. Any standard contraindication, including pregnancy, to anesthesia and/or colonoscopy

What they're measuring

Adenoma Reocurrance

Timeframe: 3 - 12 (+/- 6 months)

Trial details

NCT IDNCT06476145

SponsorAdventHealth

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-05-30

Contact for this trial

Diana Paredes, RN

407-303-5503 Diana.Paredes@adventhealth.com

View on ClinicalTrials.gov More Adenoma Colon Polyp trials